false
--12-31
0001866838
NONE
NONE
NONE
NONE
0001866838
2025-10-09
2025-10-09
0001866838
IGTA:UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueOnehalf12OfOneRedeemableWarrantAndOneRightEntitlingHolderToReceiveOnetenthOfShareOfCommonStockMember
2025-10-09
2025-10-09
0001866838
IGTA:CommonStockParValue0.0001PerShareMember
2025-10-09
2025-10-09
0001866838
IGTA:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member
2025-10-09
2025-10-09
0001866838
IGTA:RightsEachToReceiveOnetenthOfOneShareOfCommonStockMember
2025-10-09
2025-10-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event
reported): October 9, 2025
INCEPTION GROWTH ACQUISITION LIMITED
(Exact Name of Registrant as Specified in its Charter)
| Delaware |
|
001-41134 |
|
86-2648456 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
875 Washington Street
New York, NY |
|
10014 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number,
including area code: (315) 636-6638
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
| Units, each consisting of one share of common stock, $0.0001 par value, one-half (1/2) of one redeemable warrant and one right entitling the holder to receive one-tenth of a share of common stock |
|
IGTAU |
|
OTC Markets Group, Inc |
| Common Stock, par value $0.0001 per share |
|
IGTA |
|
OTC Markets Group, Inc |
| Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 |
|
IGTAW |
|
OTC Markets Group, Inc |
| Rights, each to receive one-tenth of one share of common stock |
|
IGTAR |
|
OTC Markets Group, Inc |
Item 1.01 Entry into
a Material Definitive Agreement
As
approved by its stockholders at the Special Meeting of Stockholders on October 9, 2025 (the “Meeting”), Inception Growth Acquisition
Limited (the “Company”) had on October 9, 2025 entered into an amendment (the “Trust Amendment”) to the investment
management trust agreement, as amended on March 13, 2023, September 8, 2023, June 4, 2024, December 6, 2024 and June 5, 2025, by and between
the Company and Continental Stock Transfer & Trust Company, to provide the Company with the discretion to extend the date on which
to commence liquidating the trust account (the “Trust Account”) established in connection with the Company’s initial
public offering (the “IPO”) by four (4) times for an additional one month each time from October 13, 2025 to February 13,
2026 by depositing into the trust account an aggregate amount equal to $0.075 multiplied by the number of common stock issued in the IPO
(each, a “Public Share”) that has not been redeemed for each one-month extension.
Item 5.03. Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
As
approved by its stockholders at the Meeting on October 9, 2025, the Company filed the fifth amendment to the amended and restated certificate
of incorporation on October 9, 2025 (the “Charter Amendment”), giving the Company the right to extend the date by which the
Company has to consummate a business combination from October 13, 2025 (the date that is 46 months from the closing date of the IPO) to
February 13, 2026 (the date that is 50 months from the closing date of the IPO).
Item 5.07. Submission
of Matters to a Vote of Security Holders.
On
September 10, 2025, the record date for the Meeting, there were 2,814,162 shares of common stock of the Company entitled to vote at the
Meeting. On October 9, 2025, the Company held the Meeting, of which 1,662,494 (or approximately 59.08%) shares of common stock of the
Company entitled to vote, were represented in the Meeting either in person or by proxy.
The
final results for each of the matters submitted to a vote of Company stockholders at the Meeting are as follows:
1. Charter Amendment
Stockholders
approved the proposal to amend the Company’s amended and restated certificate of incorporation, as amended on September 8, 2023,
June 4, 2024, December 6, 2024 and June 5, 2025 to extend the date by which the Company has to consummate a business combination from
October 13, 2025 (the date that is 46 months from the closing date of the IPO) to February 13, 2026 (the date that is 50 months from the
closing date of the IPO). Approval of the Charter Amendment required the approval of at least fifty percent (50%) of outstanding shares
of common stock which were present in person or by proxy and entitled to vote thereon at the Meeting. The voting results were as follows:
| FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTES |
| 1,661,934 |
|
560 |
|
0 |
|
0 |
2. Trust Amendment
Stockholders
approved the proposal to amend the Company’s investment management trust agreement, dated as of December 8, 2021, by and between
the Company and Continental Stock Transfer & Trust Company, as amended on March 13, 2023, September 8, 2023, June 4, 2024, December
6, 2024 and June 5, 2025, to provide the Company with the discretion to extend the date on which to commence liquidating the Trust Account
by four (4) times for an additional one (1) month each time from October 13, 2025 to February 13, 2026 by depositing into the trust account
an aggregate amount equal to $0.075 multiplied by the number of Public Share that has not been redeemed for each one-month extension.
Approval of the Trust Amendment required the approval of at least fifty percent (50%) of outstanding shares of common stock present in
person or by proxy and entitled to vote thereon at the Meeting. The voting results were as follows:
| FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTES |
| 1,662,374 |
|
100 |
|
0 |
|
0 |
As there were sufficient votes
to approve the above proposals, Proposal No. 3, the “Adjournment Proposal” described in the Company’s definitive proxy,
which was filed with the Securities and Exchange Commission (the “SEC”) on September 16, 2025 was not presented to the stockholders.
Item 8.01. Other Events.
In
connection with the stockholders vote at the Meeting, 100 shares of common stock were tendered for redemption. Following such redemption,
the amount of funds remaining in the trust account is approximately $2,201,073.74.
The
Company issued the press release filed herewith on October 14, 2025, which is attached as Exhibit 99.1 and incorporated by reference herein.
Item 9.01. Financial
Statements and Exhibits
(c) Exhibits:
| Exhibit No. |
|
Description |
| 3.1 |
|
Fifth Amendment to the Amended And Restated Certificate of Incorporation |
| 10.1 |
|
Amendment to the investment management trust agreement with Continental Stock Transfer & Trust Company dated as of October 9, 2025 |
| 99.1 |
|
Press Release dated October 14, 2025 |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
Inception Growth Acquisition Limited |
| |
|
| Dated: October 14, 2025 |
/s/ Cheuk Hang Chow |
| |
Cheuk Hang Chow |
| |
Chief Executive Officer |